|
Market Closed -
Nasdaq
01:30:00 17/10/2026 am IST
|
5-day change | 1st Jan Change | ||
| 157.14 USD | -2.87% |
|
-6.66% | -13.96% |
| 14/10 | Axsome Shows Valuation Disconnect Ahead of Q3, RBC Says | MT |
| 08/10 | RBC Trims Price Target on Axsome Therapeutics to $295 From $297, Keeps Outperform Rating | MT |
| Market Cap | 823.11Cr 731.66Cr 678.15Cr 617Cr 1.16TCr 78TCr 1.18TCr 8.15TCr 3.2TCr 41TCr 3.09TCr 3.02TCr 1,30000Cr | P/E 2026 * |
-54.4x | P/E 2027 * | 38.2x |
|---|---|---|---|---|---|
| Enterprise Value | 808.35Cr 718.54Cr 665.99Cr 605.94Cr 1.14TCr 77TCr 1.16TCr 8.01TCr 3.14TCr 40TCr 3.03TCr 2.97TCr 1,27600Cr | EV / Sales 2026 * |
8.49x | EV / Sales 2027 * | 5.14x |
| Free-Float |
84.69% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| AXSM | Delayed | |
CBOE
| AXSM | Real-time | |
|
Tradegate
| 19X | Real-time | |
|
London S.E.
| 0HKF | Delayed | |
|
Boerse Muenchen
| 19X | Real-time | |
|
Börse Stuttgart
| 19X | Delayed | |
|
Deutsche Boerse AG
| 19X | Delayed | |
|
Borsa Italiana
| 1AXSM | End-of-day quote | |
|
Xetra
| 19X | Delayed |
Last Transcript: Axsome Therapeutics, Inc.
| 1 day | -2.87% | ||
| 1 week | -6.66% | ||
| Current month | -14.78% | ||
| 1 month | -25.87% | ||
| 3 months | -33.71% | ||
| 6 months | -14.69% | ||
| Current year | -13.96% |
| 1 week | 155.18 |  | 170.8 |
| 1 month | 155.18 | | 213.26 |
| Current year | 152.28 | | 260.19 |
| 1 year | 123.5 | | 260.19 |
| 3 years | 55.02 | | 260.19 |
| 5 years | 20.63 | | 260.19 |
| 10 years | 1.94 | | 260.19 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 57 | 12/01/2012 | |
Nick Pizzie
DFI | Director of Finance/CFO | 51 | 16/05/2018 |
Mark Jacobson
COO | Chief Operating Officer | 42 | 01/04/2014 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 57 | 12/01/2012 | |
Roger Jeffs
BRD | Director/Board Member | 64 | 01/12/2014 |
Mark Coleman
BRD | Director/Board Member | 58 | 01/12/2014 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 03/09/26 | Exercice | Chief Operating Officer | 30,000 | 0.0573% | ||
| 06/08/26 | Exercice | Chief Executive Officer | 13,980 | 0.0272% | ||
| 01/07/26 | Exercice | Chief Executive Officer | 1,48,998 | 0.2895% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.87% | -6.66% | +25.71% | +134.85% | 823.11Cr | |
| +0.43% | +6.59% | +53.41% | +103.85% | 1,12000Cr | |
| +0.90% | -2.25% | +33.02% | +62.23% | 62TCr | |
| +0.71% | +3.24% | +25.81% | +93.86% | 50TCr | |
| -0.13% | +5.98% | +32.91% | +50.39% | 37TCr | |
| +0.52% | +0.24% | +73.92% | +40.15% | 36TCr | |
| -0.95% | +4.70% | +19.51% | +43.00% | 29TCr | |
| -1.98% | +3.73% | -0.86% | +13.43% | 26TCr | |
| -0.35% | +4.25% | +46.21% | +50.76% | 23TCr | |
| -0.75% | +3.32% | +32.53% | +97.21% | 19TCr | |
| Average | -0.45% | +2.59% | +34.22% | +68.97% | 39.49TCr | |
| Weighted average by Cap. | +0.13% | +3.81% | +39.15% | +71.57% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 95Cr 85Cr 78Cr 71Cr 134.74Cr 9.04TCr 136.9Cr 943.36Cr 369.87Cr 4.72TCr 357.5Cr 349.89Cr 15TCr | 151.86Cr 134.99Cr 125.12Cr 113.83Cr 214.81Cr 14TCr 218.25Cr 1.5TCr 589.65Cr 7.52TCr 569.93Cr 557.79Cr 24TCr |
| Net income | -15Cr -14Cr -13Cr -11Cr -21Cr -1.44TCr -22Cr -150.49Cr -59Cr -752.59Cr -57Cr -56Cr -2.4TCr | 22Cr 20Cr 18Cr 17Cr 31Cr 2.1TCr 32Cr 219.51Cr 86Cr 1.1TCr 83Cr 81Cr 3.5TCr |
| Net Debt | -15Cr -13Cr -12Cr -11Cr -21Cr -1.4TCr -21Cr -146.18Cr -57Cr -731.03Cr -55Cr -54Cr -2.33TCr | -42Cr -37Cr -35Cr -32Cr -60Cr -4TCr -61Cr -416.93Cr -163.47Cr -2.09TCr -158Cr -154.64Cr -6.65TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 16/26/16 | $157.14 | -2.87% | 8,73,152 |
| 15/26/15 | $161.79 | -0.27% | 8,02,617 |
| 14/26/14 | $162.22 | +3.77% | 8,93,237 |
| 13/26/13 | $156.32 | -5.83% | 13,28,730 |
| 12/26/12 | $166.00 | -1.40% | 6,63,002 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- AXSM Stock
Select your edition
All financial news and data tailored to specific country editions
